Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Here comes the selling pressure these license announcements bring.

Oct 03, 2008 06:11AM

Bankerson - The last report showed that Swartz still held about 20 million shares. People have been speculating that Swartz sold all his shares for the last 2 years. He always seems to have more. I would guess that he has at least 5-10 million - just a WAG.

All we can do is sit back and wait for RG to turn the Queen Mary around. A USPTO postive re-exam will speed up the process. Until then, we wait. We'll be in a great position if we can build a stock pile of cash. Cash is "more" than king right now - it is "everything".

Share
New Message
Please login to post a reply